Clinical Research Directory
Browse clinical research sites, groups, and studies.
OnaBotulinumtoxin-A in Chronic Migraine Patients With Short or Long Disease History (the BACH Study)
Sponsor: Fondazione Policlinico Universitario Campus Bio-Medico
Summary
The goal of this observational prospective multicentric study, 12 months duration is to investigate whether the history of Chronic Migraine and, more precisely, its duration for over or less than 10 years, can predict OBT-A treatment effectiveness. Since CM patients may have a complex psychopathological profile and psychiatric symptoms represent a bad prognostic factor influencing treatment effectiveness, the present study will also aim at evaluating if the psychopathological profile of the enrolled patients may influence the outcome.
Official title: OnaBotulinumtoxin-A Effectiveness Evaluation in Chronic Migraine Patients With Short or Long Disease History: an Italian Multicentric Study (the BACH Study)
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
OBSERVATIONAL
Enrollment
115
Start Date
2024-01-01
Completion Date
2025-12-31
Last Updated
2024-09-19
Healthy Volunteers
No
Conditions
Interventions
OnabotulinumtoxinA OBT-A
Patients will be re-evaluated every 3 months, at each OBT-A cycle, during the whole year of treatment. Every evaluation patients will show their diary of headaches with monthly migraine and headache days and acute medications taken.
Locations (6)
Università Politecnica delle Marche
Ancona, Italy
Università Studi dell'Aquila
L’Aquila, Italy
IRCCS Istituto Auxologico Italiano
Milan, Italy
Istituto Neurologico Besta
Milan, Italy
Fondazione Policlinico Campus Bio-Medico
Roma, Italy
Policlinico Tor Vergata
Roma, Italy